WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HR 1298

Summary — H. Res. 1298

Title: Recognizing November 8, 2025, as Premenstrual Dysphoric Disorder Awareness Day
Bill No.: H.R. 1298 (resolution)
Introduced: February 13, 2025
Status: Reported enrolled (adopted by the House on May 29, 2025)
Primary sponsor: Donald G. Davis; Cosponsor: Zachary Nunn
Related/companion bill: S. 2443

Purpose

The resolution designates November 8, 2025, as “Premenstrual Dysphoric Disorder (PMDD) Awareness Day.” Its intent is to raise public awareness about PMDD, a cyclical mood disorder associated with the menstrual cycle, and to encourage recognition, education, and support for those affected.

Key provisions

  • Officially recognizes November 8, 2025, as Premenstrual Dysphoric Disorder Awareness Day.
  • Encourages increased public awareness, educational activities, and efforts to destigmatize PMDD.
  • Urges communities, medical organizations, advocacy groups, and relevant federal agencies to observe the day through outreach, education, and supportive services.

(The text is declarative and symbolic; the resolution does not appropriate funds or create new programs.)

Who is affected

  • Individuals who experience PMDD and their families and caregivers (estimated prevalence commonly cited as a few percent of menstruating people).
  • Health-care providers and medical educators who may use the observance to promote education and best practices.
  • Advocacy and public-health organizations that conduct awareness campaigns.
  • Federal agencies and congressional offices that may choose to mark the day with events, statements, or informational materials.

Procedural history / timeline

  • Feb 13, 2025: Introduced in the House; referred to the House Committee on Ways and Means.
  • May 19, 2025: Filed.
  • May 21, 2025: Placed on Local & Consent Calendars.
  • May 29, 2025: Rules suspended; adopted by the House; reported enrolled.

“Reported enrolled” indicates the finalized resolution text has been prepared following House action. As a simple or commemorative resolution, it does not require Presidential signature and does not have the force of law beyond the formal designation.

Impact and limitations

  • Primarily symbolic: raises awareness and may catalyze educational, research, and support activities.
  • No direct funding, regulatory changes, or statutory mandates are created.
  • Potential indirect benefits include greater visibility for research needs, clinical training, and reduced stigma.

This resolution signals congressional recognition of PMDD and encourages public and private stakeholders to increase awareness and support on the designated date.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.